                         SEQUENCE LISTING

<110>  Vascular Biosciences
       Sanford-Burnham Prebys Medical Discovery Institute
       Mann, David M.
       Ruoslahti, Erkki
       Komatsu, Masanobu
 
<120>  Compositions Containing A Pharmacophore with Selectivity to 
       Diseased Tissue and Methods of Making Same

<130>  505.210WO

<150>  US 62/034,046
<151>  2014-08-06

<150>  US 62/161,121
<151>  2015-05-13

<160>  33    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  cyclic peptide

<400>  1

Cys Ala Arg Ser Lys Asn Lys Asp Cys 
1               5                   


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized

<400>  2

Cys Ala Arg Ser Arg Asn Lys Asp Cys 
1               5                   


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized

<400>  3

Cys Ala Arg Ser Lys Asn Arg Asp Cys 
1               5                   


<210>  4
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized

<400>  4

Cys Ala Arg Ser Arg Asn Arg Asp Cys 
1               5                   


<210>  5
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized

<400>  5

Cys Ala Lys Ser Arg Asn Lys Asp Cys 
1               5                   


<210>  6
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized

<400>  6

Cys Ala Lys Ser Lys Asn Arg Asp Cys 
1               5                   


<210>  7
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized

<400>  7

Cys Ala Lys Ser Lys Asn Lys Asp Cys 
1               5                   


<210>  8
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized

<400>  8

Cys Ala Lys Ser Arg Asn Arg Asp Cys 
1               5                   


<210>  9
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  cyclic peptide

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is equal to Rapamycin

<400>  9

Cys Ala Arg Ser Lys Asn Lys Asp Cys Xaa 
1               5                   10  


<210>  10
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  cyclic peptide

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is equal to Rifabutin

<400>  10

Cys Ala Arg Ser Lys Asn Lys Asp Cys Xaa 
1               5                   10  


<210>  11
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  cyclic peptide

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is equal to Voclosporin

<400>  11

Cys Ala Arg Ser Lys Asn Lys Asp Cys Xaa 
1               5                   10  


<210>  12
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized

<400>  12

Cys Ala Arg Ser Lys Asn Lys Asp Cys 
1               5                   


<210>  13
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is equal to Rapamycin

<400>  13

Cys Ala Arg Ser Lys Asn Lys Asp Cys Xaa 
1               5                   10  


<210>  14
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is equal to Rifabutin

<400>  14

Cys Ala Arg Ser Lys Asn Lys Asp Cys Xaa 
1               5                   10  


<210>  15
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is equal to Voclosporin

<400>  15

Cys Ala Arg Ser Lys Asn Lys Asp Cys Xaa 
1               5                   10  


<210>  16
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  cyclic peptide

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is equal to D-amino acid K

<400>  16

Cys Ala Arg Ser Lys Asn Xaa Asp Cys 
1               5                   


<210>  17
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  cyclic peptide

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is equal to D-amino acid allylglycine

<400>  17

Cys Xaa Arg Ser Lys Asn Lys Asp Cys 
1               5                   


<210>  18
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  cyclic peptide

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is equal to D-amino acid N

<400>  18

Cys Ala Xaa Ser Lys Asn Lys Asp Cys 
1               5                   


<210>  19
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  cyclic peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is equal to N-methylated C

<400>  19

Xaa Ala Arg Ser Lys Asn Lys Asp Cys 
1               5                   


<210>  20
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is equal to D-amino acid K

<400>  20

Cys Ala Arg Ser Xaa Asn Lys Asp Cys 
1               5                   


<210>  21
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is equal to D-amino acid allylglycine

<400>  21

Cys Xaa Arg Ser Lys Asn Lys Asp Cys 
1               5                   


<210>  22
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is equal to D-amino acid N

<400>  22

Cys Ala Xaa Ser Lys Asn Lys Asp Cys 
1               5                   


<210>  23
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is equal to N-methylated C

<400>  23

Xaa Ala Arg Ser Lys Asn Lys Asp Cys 
1               5                   


<210>  24
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized

<400>  24

Cys Ala Arg Ser Lys Asn Lys 
1               5           


<210>  25
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is equal to D-amino acid K

<400>  25

Cys Ala Arg Ser Xaa Asn Lys 
1               5           


<210>  26
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is equal to D-allylglycine

<400>  26

Cys Xaa Arg Ser Lys Asn Lys 
1               5           


<210>  27
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is equal to D-amino acid N

<400>  27

Cys Ala Xaa Ser Lys Asn Lys 
1               5           


<210>  28
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is equal to N-methylated C

<400>  28

Xaa Ala Arg Ser Lys Asn Lys 
1               5           


<210>  29
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is equal to HSA, human serum albumin

<400>  29

Xaa Cys Ala Arg Ser Lys Asn Lys 
1               5               


<210>  30
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  cyclic peptide

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is equal to Fv fragment of B1 antibody

<400>  30

Cys Ala Arg Ser Lys Asn Lys Asp Lys Xaa 
1               5                   10  


<210>  31
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized

<400>  31

Leu Ala Arg Ser Lys Asn Lys Asp Leu 
1               5                   


<210>  32
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized

<400>  32

Cys Ala Lys Ser Arg Asn His Asp Cys 
1               5                   


<210>  33
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized

<400>  33

Cys Ala Arg Ser Lys Asn Lys Leu Cys 
1               5                   


